Rostab EZ Tablet 20 mg+10 mg is a high-potency combination tablet containing Rosuvastatin Calcium 20 mg and Ezetimibe 10 mg, specifically formulated for adults who require intensive lipid-lowering therapy. This combination is ideal for patients with primary hypercholesterolemia, mixed dyslipidemia, or familial hypercholesterolemia, particularly those who have not achieved target cholesterol levels with monotherapy.
Rosuvastatin, a potent HMG-CoA reductase inhibitor, reduces cholesterol synthesis in the liver, while Ezetimibe selectively blocks intestinal absorption of cholesterol. The synergistic effect of these two agents produces significant reduction in low-density lipoprotein (LDL) cholesterol, total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein (HDL) cholesterol. By targeting cholesterol production and absorption simultaneously, Rostab EZ 20 mg+10 mg offers maximized efficacy and cardiovascular protection.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Each tablet contains:
Rosuvastatin Calcium 20 mg
Ezetimibe 10 mg
Excipients: Microcrystalline cellulose, lactose, magnesium stearate, and other standard tablet excipients
Rostab EZ Tablet 20 mg+10 mg is indicated for:
Primary hypercholesterolemia to lower LDL and total cholesterol
Mixed dyslipidemia with elevated LDL and triglycerides
Familial hypercholesterolemia as an adjunct to diet and lifestyle modification
Adults requiring intensive lipid-lowering therapy when monotherapy is insufficient
Prevention of cardiovascular events, including myocardial infarction, stroke, and angina, in high-risk patients
Rostab EZ combines two complementary mechanisms to manage lipid levels effectively:
Rosuvastatin Calcium:
Inhibits HMG-CoA reductase, a key enzyme in hepatic cholesterol synthesis
Reduces LDL cholesterol and triglycerides, while slightly increasing HDL cholesterol
Stabilizes atherosclerotic plaques and improves endothelial function
Ezetimibe:
Blocks cholesterol absorption at the intestinal brush border
Reduces cholesterol delivery to the liver
Enhances LDL-lowering effects when combined with Rosuvastatin
The combination provides greater cholesterol-lowering efficacy than either agent alone, making it suitable for patients with high cardiovascular risk or refractory hyperlipidemia.
Adults: 1 tablet once daily, with or without food
Preferably taken in the evening, when hepatic cholesterol synthesis is highest
Continue dietary modifications, regular exercise, and weight management alongside medication
Regular monitoring of lipid profile, liver function, and kidney function is recommended
Dose adjustments may be made by the physician based on response and tolerability
Avoid use in patients with active liver disease or unexplained persistent liver enzyme elevations
Use cautiously in patients with renal impairment or history of muscle disorders
Inform your physician about all medications being taken to prevent interactions, especially with CYP3A4 inhibitors
Not recommended during pregnancy or breastfeeding
Seek immediate medical attention for unexplained muscle pain, tenderness, or weakness, which may indicate rhabdomyolysis
Rostab EZ Tablet 20 mg+10 mg is generally well tolerated. Common side effects may include:
Headache
Gastrointestinal discomfort (nausea, abdominal pain)
Muscle pain, stiffness, or weakness
Temporary elevation of liver enzymes
Rarely, serious muscle injury (rhabdomyolysis)
Most adverse effects are mild, transient, and manageable with dose adjustment or discontinuation under medical supervision.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Store below 30°C in a cool, dry place
Protect from light and moisture
Keep out of reach of children
Rostab EZ Tablet 20 mg+10 mg (Rosuvastatin + Ezetimibe) is a high-potency combination therapy for adults who need intensive cholesterol management. By targeting both cholesterol synthesis and absorption, it effectively lowers LDL cholesterol, reduces triglycerides, and improves overall lipid profile. When used alongside lifestyle modifications, Rostab EZ supports cardiovascular risk reduction and long-term heart health.
Login Or Registerto submit your questions to seller
No none asked to seller yet